Skip to main content
. 2022 Mar 23;7(1):e000977. doi: 10.1136/bmjophth-2022-000977

Table 2.

Association between orbito-ocular cancers and demographic variables and site of lesion

Variable Cancer (%) No cancer (%) Unadjusted OR (95% CI)* Adjusted OR (95% CI)†
Sex Female 45 (35.7) 81 (64.3)
Male 39 (46.4) 45 (53.6) 1.6 (0.8 to 2.7) 1.5 (0.7 to 2.8)
Age (years) 0–10 (reference) 10 (45.5) 12 (54.5)
11–20 1 (11.1) 8 (88.9) 0.2 (0.0 to 1.4) 0.2 (0.0 to 2.2)
21–30 10 (26.3) 28 (73.7) 0.4 (0.1 to 1.3) 0.7 (0.2 to 2.7)
31–40 29 (45.3) 35 (54.7) 1.0 (0.4 to 2.6) 1.5 (0.4 to 5.3)
41–50 27 (56.3) 21 (43.7) 1.5 (0.6 to 4.3) 1.9 (0.5 to 6.7)
51–60 4 (22.2) 14 (77.8) 0.3 (0.1 to 1.4) 0.3 (0.1 to 1.6)
61–70 1 (16.7) 5 (83.3) 0.2 (0.0 to 2.4) 0.7 (0.1 to 7.8)
>70 1 (50.0) 1 (50.0) 1.2 (0.1 to 21.7) 1.1 (0.0 to 39. 9)
HIV status Negative (reference) 11 (22.9) 37 (78.1)
Positive 25 (67.6) 12 (32.4) 7.0 (2.7 to 18.4) 5.9 (2.0 to 17.2)
Unknown 48 (38.4) 77 (61.6) 2.1 (0.9 to 4.5) 1.9 (0.8 to 4.6)
Site Eye lid/adnexa (reference) 6 (21.4) 22 (78.6)
Conjunctiva 54 (40.3) 80 (59.7) 2.5 (0.9 to 6.5) 1.9 (0.6 to 5.4)
Intraocular 18 (72.0) 7 (28.0) 9.4 (2.7 to 33.1) 8.3 (2.0 to 33.8)
Not specified 6 (26.1) 17 (73.9) 1.3 (0.4 to 4.7) 0.7 (0.2 to 2.9)

*Univariable binary logistic regression.

†Multivariable binary logistic regression, adjusting for all other variables in the table.